We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Mutations in LINC Genes Cause Rare Inherited Hearing Loss

By LabMedica International staff writers
Posted on 12 Feb 2013
A unique case of familial hearing loss has been attributed to mutations in LINC family proteins expressed in the hair cells of the inner ear.

Investigators at Tel Aviv University (Israel) were attempting to explain the genetic mechanism that caused progressive high-frequency hearing loss in two families of Iraqi Jewish ancestry.

They reported in the January 25, 2013, online edition of the Journal of Clinical Investigation that the defect was due to homozygosity for a protein truncating mutation in SYNE4, a gene not previously associated with hearing loss. More...
This gene encodes the protein nesprin-4 (NESP4), an outer nuclear membrane (ONM) protein expressed in the hair cells of the inner ear. This protein, NESP4, and the SUN domain-containing protein 1 (SUN1), which localizes to the inner nuclear membrane (INM), are components of the LINC (linker of nucleoskeleton and cytoskeleton) complex in the nuclear envelope.

The LINC-complex is a protein complex associated with both inner and outer membranes of the nucleus and actin in the microfilament cytoskeleton. This complex is involved in the anchoring of both nuclear membranes and nuclear lamina to the actin cytoskeleton via transmembrane proteins. The LINC complex consists of SUN2 and Samp1 of the inner nuclear membrane and nesprin-2G of the outer nuclear membrane. SUN2 anchors to the nuclear lamina aided by Samp1, while nesprin-2G associates with the actin microfilaments.

To better understand the connection between the LINC proteins and hearing loss, the investigators studied lines of mice that had been genetically engineered to lack a specific LINC gene. They found that in mice lacking both Nesp4 and SUN1, outer hair cells (OHCs) formed normally, but degenerated as hearing matured, leading to progressive hearing loss. The nuclei of OHCs from mutant mice failed to maintain their basal localization, potentially affecting cell motility and hence the response to sound.

These results demonstrated that the LINC complex was essential for viability and normal morphology of OHCs and suggested that the position of the nucleus in sensory epithelial cells was critical for maintenance of normal hearing.

"The cell nucleus, which contains our entire DNA, moves to the top of the cell rather than being anchored to the bottom, its normal place. Though this has little impact on the functioning of most of the body's cells, it is devastating for the cells responsible for hearing," said senior author Dr. Keren Avraham, professor of human molecular genetics and biochemistry at Tel Aviv University. "The position of the nucleus is important for receiving the electrical signals that determine proper hearing. Without the ability to receive these signals correctly, the entire cascade of hearing fails. Now that we have reported it, scientists around the world can test for mutations in this gene."

Related Links:
Tel Aviv University




Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Parainfluenza Virus Test
PARAINFLUENZA ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.